Damage-associated molecular patterns and their role as initiators of inflammatory and auto-immune signals in systemic lupus erythematosus

References

• Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991–1045.
   PubMed Web of Science ®Google Scholar
• Matzinger P. The danger model: a renewed sense of self. Science 2002;296(5566):301–305.
   PubMed Web of Science ®Google Scholar
• Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004;4(6):469–478.
   PubMed Web of Science ®Google Scholar
• Hsieh LT-H, Nastase M-V, Zeng-Brouwers J, et al. Soluble biglycan as a biomarker of inflammatory renal diseases. Int J Biochem Cell Biol 2014;54:223–235.
   PubMed Web of Science ®Google Scholar
• Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81(1):1–5.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes. Swiss Med Wkly 2011;141:w13256.
   PubMed Web of Science ®Google Scholar
• Bausero MA, Gastpar R, Multhoff G, et al. Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72. J Immunol 2005;175(5):2900–2912.
   PubMed Web of Science ®Google Scholar
• Ryan BJ, Nissim A, Winyard PG. Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases. Redox Biol 2014;2:715–724.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. The translocation of nuclear molecules during inflammation and cell death. Antioxid Redox Signal 2014;20(7):1117–1125.
   PubMed Web of Science ®Google Scholar
• Lim SY, Raftery MJ, Goyette J, et al. Oxidative modifications of S100 proteins: functional regulation by redox. J Leukoc Biol 2009;86(3):577–587
   PubMed Web of Science ®Google Scholar
• Miller YI, Choi SH, Wiesner P, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 2011;108(2):235–248.
   PubMed Web of Science ®Google Scholar
• Schaefer L, Babelova A, Kiss E, et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005;115(8):2223–2233.
   PubMed Web of Science ®Google Scholar
• Schaefer L, Beck KF, Raslik I, et al. Biglycan, a nitric oxide-regulated gene, affects adhesion, growth, and survival of mesangial cells. J Biol Chem 2003;278(28):26227–26237.
   PubMed Web of Science ®Google Scholar
• Babelova A, Moreth K, Tsalastra-Greul W, et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 2009;284(36):24035–24048.
   PubMed Web of Science ®Google Scholar
• Termeer CC, Hennies J, Voith U, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000;165(4):1863–1870.
   PubMed Web of Science ®Google Scholar
• Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195(1):99–111.
   PubMed Web of Science ®Google Scholar
• Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005;11(11):1173–1179.
   PubMed Web of Science ®Google Scholar
• Taylor KR, Trowbridge JM, Rudisill JA, et al. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004;279(17):17079–17084.
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Muto J, Taylor KR, et al. NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 2009;284(19):12762–12771.
   PubMed Web of Science ®Google Scholar
• Labat-Robert J. Cell-Matrix interactions, the role of fibronectin and integrins. A survey. Pathol Biol (Paris) 2012;60(1):15–29.
   PubMed Web of Science ®Google Scholar
• Austin BA, Liu B, Li Z, et al. Biologically active fibronectin fragments stimulate release of MCP-1 and catabolic cytokines from murine retinal pigment epithelium. Invest Ophthalmol Vis Sci 2009;50(6):2896–2902.
   PubMed Web of Science ®Google Scholar
• Lefebvre JS, Levesque T, Picard S, et al. Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4. Arthritis Rheum 2011;63(6):1527–1533.
   PubMed Web of Science ®Google Scholar
• Gondokaryono SP, Ushio H, Niyonsaba F, et al. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 2007;82(3):657–665.
   PubMed Web of Science ®Google Scholar
• Magna M, Pisetsky DS. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med 2014;20:138–146.
   PubMed Web of Science ®Google Scholar
• Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 2012;8(4):195–202.
   PubMed Web of Science ®Google Scholar
• Bonaldi T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003;22(20):5551–5560.
   PubMed Web of Science ®Google Scholar
• Youn JH, Shin, JS. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006;177(11):7889–7897.
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418(6894):191–195.
   PubMed Web of Science ®Google Scholar
• Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5(4):331–342.
   PubMed Web of Science ®Google Scholar
• Lotze MT, Zeh HJ, Rubartelli A, et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007;220:60–81.
   PubMed Web of Science ®Google Scholar
• Venereau E, Casalgrandi M, Schiraldi M, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 2012;209(9):1519–1528.
   PubMed Web of Science ®Google Scholar
• Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 2010;107(26):11942–11947.
   PubMed Web of Science ®Google Scholar
• Wahamaa H, Schierbeck H, Hreggvidsdottir HS, et al. High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res Ther 2011;13(4):R136.
   PubMed Web of Science ®Google Scholar
• Hreggvidsdottir HS, stberg TO, Wahamaa H, et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009;86(3):655–662.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. The origin and properties of extracellular DNA: from PAMP to DAMP. Clin Immunol 2012;144(1):32–40.
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Vogl T, et al. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007;81(1):28–37.
   PubMed Web of Science ®Google Scholar
• Vogl T, Tenbrock K, Ludwig S, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007;13(9):1042–1049.
   PubMed Web of Science ®Google Scholar
• Ryckman C, Vandal K, Rouleau P, et al. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003;170(6):3233–3242.
   PubMed Web of Science ®Google Scholar
• Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97(7):889–901.
   PubMed Web of Science ®Google Scholar
• Tamura Y, Yoneda A, Takei N, et al. Spatiotemporal Regulation of Hsp90-Ligand Complex Leads to Immune Activation. Front Immunol 2016;7:201.
   PubMed Web of Science ®Google Scholar
• Dubaniewicz A. Microbial and human heat shock proteins as ‘danger signals’ in sarcoidosis. Hum Immunol 2013;74(12):1550–1558.
   PubMed Web of Science ®Google Scholar
• Okuya K, Tamura Y, Saito K, et al. Spatiotemporal regulation of heat shock protein 90-chaperoned self-DNA and CpG-oligodeoxynucleotide for type I IFN induction via targeting to static early endosome. J Immunol 2010;184(12):7092–7099.
   PubMed Web of Science ®Google Scholar
• Saito K, Kukita K, Kutomi G, et al. Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE. Eur J Immunol 2015;45(7):2028–2041.
   PubMed Web of Science ®Google Scholar
• Ohashi K, Burkart V, Flohé S, et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000;164(2):558–561.
   PubMed Web of Science ®Google Scholar
• Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000;6(4):435–442.
   PubMed Web of Science ®Google Scholar
• Kono H, Rock KL. Rock, How dying cells alert the immune system to danger. Nat Rev Immunol 2008;8(4):279–289.
   PubMed Web of Science ®Google Scholar
• di Giovine FS, Malawista SE, Thornton E, et al. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991;87(4):1375–1381.
   PubMed Web of Science ®Google Scholar
• Guerne PA, Terkeltaub R, Zuraw B, et al. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989;32(11):1443–1452.
   PubMed Web of Science ®Google Scholar
• Duff GW, Atkins E, Malawista SE. The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. Trans Assoc Am Physicians 1983;96:234–245.
   PubMedGoogle Scholar
• Liu R, O'Connell M, Johnson K, et al. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells. Arthritis Rheum 2000;43(5):1145–1155.
   PubMed Web of Science ®Google Scholar
• Pouliot M, James MJ, McColl SR, et al. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998;91(5):1769–1776.
   PubMed Web of Science ®Google Scholar
• Jaramillo M, Godbout M, Naccache PH, et al. Signaling events involved in macrophage chemokine expression in response to monosodium urate crystals. J Biol Chem 2004;279(50):52797–52805.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Scott P, Sydlaske A, et al. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005;52(9):2936–2946.
   PubMed Web of Science ®Google Scholar
• Gallo PM, Gallucci S. The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front Immunol 2013;4:138.
   Google Scholar
• Piccini A, Carta S, Tassi S, et al. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A 2008;105(23):8067–8072.
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Thompson LF, Karhausen J, et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 2004;104(13):3986–3992.
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Eckle T, Mager A, et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 2006;99(10):1100–1108.
   PubMed Web of Science ®Google Scholar
• Karmakar M, Katsnelson MA, Dubyak GR, et al. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1beta secretion in response to ATP. Nat Commun 2016;7:10555.
   PubMed Web of Science ®Google Scholar
• Mankan AK, Dau T, Jenne D, et al. The NLRP3/ASC/Caspase-1 axis regulates IL-1beta processing in neutrophils. Eur J Immunol 2012;42(3):710–715.
   PubMed Web of Science ®Google Scholar
• Schnurr M, Then F, Galambos P, et al. Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol 2000;165(8):4704–4709.
   PubMed Web of Science ®Google Scholar
• Urbonaviciute V, Furnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008;205(13):3007–3018.
   PubMed Web of Science ®Google Scholar
• Kariko K, Ni H, Capodici J, et al. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004;279(13):12542–12550.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464(7285):104–107.
   PubMed Web of Science ®Google Scholar
• Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem 2014;289(51):35237–35245.
   PubMed Web of Science ®Google Scholar
• Rosin DL, Okusa MD. Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 2011;22(3):416–425.
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Ramalingam T, et al. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001;14(3):303–313.
   PubMed Web of Science ®Google Scholar
• Komai K, Shichita T, Ito M, et al. Role of scavenger receptors as damage-associated molecular pattern receptors in Toll-like receptor activation. Int Immunol 2017;29(2):59–70.
   PubMed Web of Science ®Google Scholar
• Feldman N, Rotter-Maskowitz A, Okun E. DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev 2015;24(Pt A):29–39.
   PubMed Web of Science ®Google Scholar
• Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010;2010.
   Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4(7):499–511.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276(7):4812–4818.
   PubMed Web of Science ®Google Scholar
• Xie J, Méndez JD, Méndez-Valenzuela V, et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal 2013;25(11):2185–2197.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Gardner SE, Clarke MC. Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 2011;31(12):2781–2786.
   PubMed Web of Science ®Google Scholar
• Rani SG, Sepuru KM, Yu C. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE). Biochim Biophys Acta 2014;1844(9):1718–1728.
   PubMed Web of Science ®Google Scholar
• Chaney MO, Stine WB, Kokjohn TA, et al. RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. Biochim Biophys Acta 2005;1741(1–2):199–205.
   PubMed Web of Science ®Google Scholar
• Chen GY, Nunez G. Nunez, Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010;10(12):826–837.
   PubMed Web of Science ®Google Scholar
• Tveita AA. The danger model in deciphering autoimmunity. Rheumatology (Oxford) 2010;49(4):632–639.
   PubMed Web of Science ®Google Scholar
• Lu M, Yu S, Xu W, et al. HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response. J Immunol Res 2015;2015:946748.
   PubMedGoogle Scholar
• Yoshizaki A, Komura K, Iwata Y, et al. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity. J Clin Immunol 2009;29(2):180–189.
   PubMed Web of Science ®Google Scholar
• Kane D, Roth J, Frosch M, et al. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum 2003;48(6):1676–1685.
   PubMed Web of Science ®Google Scholar
• Foell D, Kane D, Bresnihan B, et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003;42(11):1383–1389.
   PubMed Web of Science ®Google Scholar
• Panchapakesan J, Daglis M, Gatenby P. Antibodies to 65 kDa and 70 kDa heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol 1992;70(Pt 5):295–300.
   PubMed Web of Science ®Google Scholar
• Ghoreishi M, Katayama I, Yokozeki H, et al. Analysis of 70 KD heat shock protein (HSP70) expression in the lesional skin of lupus erythematosus (LE) and LE related diseases. J Dermatol 1993;20(7):400–405.
   PubMedGoogle Scholar
• Bjork J, Kleinau S, Tengblad A, et al. Elevated levels of serum hyaluronate and correlation with disease activity in experimental models of arthritis. Arthritis Rheum 1989;32(3):306–311.
   PubMed Web of Science ®Google Scholar
• O'Reilly S. Pound the alarm: danger signals in rheumatic diseases. Clin Sci (Lond) 2015;128(5):297–305.
   PubMed Web of Science ®Google Scholar
• Roelofs MF, Boelens WC, Joosten LA, et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006;176(11):7021–7027.
   PubMed Web of Science ®Google Scholar
• Nielsen CT. Circulating microparticles in systemic Lupus Erythematosus. Dan Med J 2012;59(11):B4548.
   PubMed Web of Science ®Google Scholar
• Schiller M, Bekeredjian-Ding I, Heyder P, et al. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 2008;15(1):183–191.
   PubMed Web of Science ®Google Scholar
• Herrmann M, Voll RE, Zoller OM, et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41(7):1241–1250.
   PubMed Web of Science ®Google Scholar
• Shao WH, Cohen PL. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther 2011;13(1):202.
   PubMed Web of Science ®Google Scholar
• Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and disease. J Cell Biol 2010;189(7):1059–1070.
   PubMed Web of Science ®Google Scholar
• Lorenz HM, Grunke M, Hieronymus T, et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997;40(2):306–317.
   PubMed Web of Science ®Google Scholar
• Hepburn AL, Lampert IA, Boyle JJ, et al. In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann Rheum Dis 2007;66(8):1106–1109.
   PubMed Web of Science ®Google Scholar
• Kuhn A, Herrmann M, Kleber S, et al. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 2006;54(3):939–950.
   PubMed Web of Science ®Google Scholar
• Tas SW, Quartier P, Botto M, et al. Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis 2006;65(2):216–221.
   PubMed Web of Science ®Google Scholar
• Yassin LM, Rojas M, Ramirez LA, et al. Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients. Cell Immunol 2010;266(1):52–60.
   PubMed Web of Science ®Google Scholar
• Land WG. The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I – Promoting inflammation and immunity. Sultan Qaboos Univ Med J 2015;15(1):e9–e21.
   PubMedGoogle Scholar
• Leadbetter EA, Rifkin IR, Hohlbaum AM, et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416(6881):603–607.
   PubMed Web of Science ®Google Scholar
• Ardoin SP, Pisetsky DS. The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation. Mod Rheumatol 2008;18(4):319–326.
   PubMed Web of Science ®Google Scholar
• Ripley BJ, Isenberg DA, Latchman DS. Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90. J Autoimmun 2001;17(4):341–346.
   PubMed Web of Science ®Google Scholar
• Popovic K, Ek M, Espinosa A, et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 2005;52(11):3639–3645.
   PubMed Web of Science ®Google Scholar
• Loser K, Vogl T, Voskort M, et al. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 2010;16(6):713–717.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li C, Jia S, et al. High-mobility group box 1 inhibition alleviates lupus-like disease in BXSB mice. Scand J Immunol 2014;79(5):333–337.
   PubMed Web of Science ®Google Scholar
• Werwitzke S, Trick D, Kamino K, et al. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Arthritis Rheum 2005;52(11):3629–3638.
   PubMed Web of Science ®Google Scholar